Works by Beeram, Muralidhar

Results: 14
    1
    2

    Phase I and pharmacokinetic study of cisplatin and troxacitabine administered intravenously every 28 days in patients with advanced solid malignancies.

    Published in:
    Cancer Chemotherapy & Pharmacology, 2009, v. 65, n. 1, p. 167, doi. 10.1007/s00280-009-1020-y
    By:
    • Chia-Chi Lin;
    • Beeram, Muralidhar;
    • Rowinsky, Eric K.;
    • Takimoto, Chris H.;
    • Ng, Chee M.;
    • Geyer Jr., Charles E.;
    • Denis, Louis J.;
    • De Bono, Johann S.;
    • Hao, Desiree;
    • Tolcher, Anthony W.;
    • Rha, Sun-Young;
    • Jolivet, Jacques;
    • Patnaik, Amita
    Publication type:
    Article
    3
    4

    Clinical Implications of Pathophysiological and Demographic Covariates on the Population Pharmacokinetics of Trastuzumab Emtansine, a HER2-Targeted Antibody-Drug Conjugate, in Patients With HER2-Positive Metastatic Breast Cancer.

    Published in:
    Journal of Clinical Pharmacology, 2012, v. 52, n. 5, p. 691, doi. 10.1177/0091270011403742
    By:
    • Gupta, Manish;
    • LoRusso, Patricia M.;
    • Wang, Bei;
    • Yi, Joo-Hee;
    • Burris, Howard A.;
    • Beeram, Muralidhar;
    • Modi, Shanu;
    • Chu, Yu-Waye;
    • Agresta, Samuel;
    • Klencke, Barbara;
    • Joshi, Amita;
    • Girish, Sandhya
    Publication type:
    Article
    5
    6
    7

    Two Phase 1 dose-escalation studies exploring multiple regimens of litronesib (LY2523355), an Eg5 inhibitor, in patients with advanced cancer.

    Published in:
    2017
    By:
    • Infante, Jeffrey;
    • Patnaik, Amita;
    • Verschraegen, Claire;
    • Olszanski, Anthony;
    • Shaheen, Montaser;
    • Burris, Howard;
    • Tolcher, Anthony;
    • Papadopoulos, Kyriakos;
    • Beeram, Muralidhar;
    • Hynes, Scott;
    • Leohr, Jennifer;
    • Lin, Aimee;
    • Li, Lily;
    • McGlothlin, Anna;
    • Farrington, Daphne;
    • Westin, Eric;
    • Cohen, Roger;
    • Infante, Jeffrey R;
    • Verschraegen, Claire F;
    • Olszanski, Anthony J
    Publication type:
    journal article
    8

    Phase II study evaluating the efficacy, safety, and pharmacodynamic correlative study of dual antiangiogenic inhibition using bevacizumab in combination with sorafenib in patients with advanced malignant melanoma.

    Published in:
    Cancer Chemotherapy & Pharmacology, 2014, v. 74, n. 1, p. 77, doi. 10.1007/s00280-014-2479-8
    By:
    • Mahalingam, Devalingam;
    • Malik, Laeeq;
    • Beeram, Muralidhar;
    • Rodon, Jordi;
    • Sankhala, Kamalesh;
    • Mita, Alain;
    • Benjamin, Daniel;
    • Ketchum, Norma;
    • Michalek, Joel;
    • Tolcher, Anthony;
    • Wright, John;
    • Sarantopoulos, John
    Publication type:
    Article
    9

    A Phase Ib study evaluating MNRP1685A, a fully human anti-NRP1 monoclonal antibody, in combination with bevacizumab and paclitaxel in patients with advanced solid tumors.

    Published in:
    Cancer Chemotherapy & Pharmacology, 2014, v. 73, n. 5, p. 951, doi. 10.1007/s00280-014-2426-8
    By:
    • Patnaik, Amita;
    • LoRusso, Patricia;
    • Messersmith, Wells;
    • Papadopoulos, Kyriakos;
    • Gore, Lia;
    • Beeram, Muralidhar;
    • Ramakrishnan, Vanitha;
    • Kim, Amy;
    • Beyer, Joseph;
    • Mason Shih, L.;
    • Darbonne, Walter;
    • Xin, Yan;
    • Yu, Ron;
    • Xiang, Hong;
    • Brachmann, Rainer;
    • Weekes, Colin
    Publication type:
    Article
    10
    11

    Abemaciclib in Combination With Endocrine Therapy for Patients With Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer: A Phase 1b Study.

    Published in:
    Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2021.810023
    By:
    • Tolaney, Sara M.;
    • Beeram, Muralidhar;
    • Beck, J. Thaddeus;
    • Conlin, Alison;
    • Dees, E. Claire;
    • Puhalla, Shannon L.;
    • Rexer, Brent N.;
    • Burris 3rd, Howard A.;
    • Jhaveri, Komal;
    • Helsten, Teresa;
    • Becerra, Carlos;
    • Kalinsky, Kevin;
    • Moore, Kathleen N.;
    • Manuel, Allison M.;
    • Lithio, Andrew;
    • Price, Gregory L.;
    • Chapman, Sonya C.;
    • Litchfield, Lacey M.;
    • Goetz, Matthew P.
    Publication type:
    Article
    12
    13
    14